The company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.

Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully e ...

Among the major classes of RNAs in the cell, tRNAs remain the most difficult to characterize via deep sequencing approaches, as tRNA structure and nucleotide modifications can each interfere with cDNA ...

The orphan drug designation is particularly noteworthy as it can provide Dyne with a range of benefits, including reduced regulatory fees, assistance with clinical protocols, eligibility for research ...

This year's Futures National Conference, hosted by CureDuchenne for the Duchenne and Becker MD communities, is scheduled to ...

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The New York Jets, under new head coach Aaron Glenn and general manager Darren Mougey, have put the wheels in motion to kickstart this new regime in a positive mindset in 2025. Justin Fields is ...